CLGN · Company research

CollPlant Biotechnologies Ltd Ordinary Shares (CLGN): Valuation Analysis

Available valuation snapshots and ratios; unavailable metrics remain blank.

RESEARCH CONTEXT

Understand the numbers

Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.

1records availableHealthcare

Valuation Analysis data

Database-backed records only

1 rows
valuation datepricemarket capenterprise valuepeforward pepegprice salesprice bookprice fcf
Oct 8, 20263.46$7,506,559.3737242474.19———20.43314126107127797.9669425966123993—

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.